Cargando…
Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia
BACKGROUND: People who inject drugs (PWID) in Georgia have a high prevalence of hepatitis C virus antibody (anti-HCV). Access to care among PWID could be prioritized to meet the country’s hepatitis C elimination goals. This study assesses barriers of linkage to HCV viremia testing among PWID in Geor...
Autores principales: | Butsashvili, Maia, Abzianidze, Tinatin, Kamkamidze, George, Gulbiani, Lasha, Gvinjilia, Lia, Kuchuloria, Tinatin, Tskhomelidze, Irina, Gogia, Maka, Tsereteli, Maia, Miollany, Veronique, Kikvidze, Tamar, Shadaker, Shaun, Nasrullah, Muazzam, Averhoff, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962019/ https://www.ncbi.nlm.nih.gov/pubmed/35346265 http://dx.doi.org/10.1186/s13011-022-00438-6 |
Ejemplares similares
-
Seroconversion of hepatitis B vaccine among patients from outpatient clinic in Georgia
por: Kanchelashvili, Giorgi, et al.
Publicado: (2023) -
Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
por: Stvilia, Ketevan, et al.
Publicado: (2019) -
High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2020) -
Knowledge, attitude and practice regarding COVID-19 vaccination among HCV infected patients in Georgia
por: Gulbiani, Lasha, et al.
Publicado: (2022) -
The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination — Georgia, 2015–2016
por: Nasrullah, Muazzam, et al.
Publicado: (2017)